Showing results (1-10 of 3,237) with videos related to

Sort By:
Pageof 324
Atherosclerosis. Supplements|May 5, 2015
An elevated lipoprotein(a) plasma level as a cardiovascular risk factorS Tselmin, G Müller, E Gelgaft, et al.
Atherosclerosis. Supplements|February 5, 2010
Cardiovascular events in patients with increased lipoprotein (a) - retrospective data analysis in an outpatient department of lipid disordersS Tselmin, U Julius, G Müller, et al.
Atherosclerosis. Supplements|May 5, 2015
Hypertriglyceridemia in an outpatient department--Significance as an atherosclerotic risk factorM Scholz, S Tselmin, S Fischer, et al.
Atherosclerosis. Supplements|November 4, 2017
Most significant reduction of cardiovascular events in patients undergoing lipoproteinapheresis due to raised Lp(a) levels - A multicenter observational studyU Schatz, S Tselmin, G Müller, et al.
Atherosclerosis. Supplements|January 30, 2013
Homocysteine in lipoprotein apheresis patients--retrospective data analysis in apheresis center of a university hospitalS Tselmin, R N Rodionov, G Müller, et al.
Clinical Research in Cardiology Supplements|March 7, 2019
Lipoprotein(a) and proprotein convertase subtilisin/kexin type 9 inhibitorsU Julius, S Tselmin, U Schatz, et al.
Clinical Research in Cardiology Supplements|March 7, 2019
Lipoprotein(a)-an interdisciplinary challengeU Julius, S Tselmin, U Schatz, et al.
Atherosclerosis. Supplements|November 4, 2017
Kinetics of Lipoprotein(a) in patients undergoing weekly lipoprotein apheresis for Lp(a) hyperlipoproteinemiaS Tselmin, G Müller, U Schatz, et al.
Atherosclerosis. Supplements|January 30, 2013
Nicotinic acid as a lipid-modifying drug--a reviewU Julius, S Fischer
Atherosclerosis. Supplements|January 30, 2013
Differences in the atherogenic risk of patients treated by lipoprotein apheresis according to their lipid patternM von Dryander, S Fischer, J Passauer, et al.
Pageof 324